| Literature DB >> 21350496 |
Abstract
A new study uses genome-wide SNP genotypes to identify a subset of children undergoing therapy for acute lymphoblastic leukemia that are at increased risk for relapse. Borrowing from the classical approach of admixture mapping, the work shows how genome-wide assessment of genetic ancestry can be used as a biomarker for disease outcome.Entities:
Mesh:
Year: 2011 PMID: 21350496 DOI: 10.1038/ng0311-178
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330